Terms: = Cervical cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
209 results:
1. Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway.
Zhang Y; Lei Y; Ou Q; Chen M; Tian S; Tang J; Li R; Liang Q; Chen Z; Wang C
BMC Biol; 2024 Apr; 22(1):88. PubMed ID: 38641823
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic and therapeutic potential of stat3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.
Janjua D; Thakur K; Aggarwal N; Chaudhary A; Yadav J; Chhokar A; Tripathi T; Joshi U; Senrung A; Bharti AC
Crit Rev Oncol Hematol; 2024 May; 197():104346. PubMed ID: 38608913
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence of PD-L1 in cervical cancer Patients and the Potential for Combining an Immune Checkpoint Inhibitor With Lenvatinib.
Bräutigam K; Schmidt T; Baur M; Tauber N; Kontomanolis EN; Hemptenmacher F; Rody A; Köster F
Anticancer Res; 2024 Feb; 44(2):503-510. PubMed ID: 38307554
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPα axis.
Chen XJ; Guo CH; Wang ZC; Yang Y; Pan YH; Liang JY; Sun MG; Fan LS; Liang L; Wang W
Cell Commun Signal; 2024 Jan; 22(1):15. PubMed ID: 38183060
[TBL] [Abstract] [Full Text] [Related]
5. Preparation of polypeptide-metal complexes-coated Hosenkoside A and its inhibitory effect in cervical cancer.
Wang Y; Lou C; Zhao S; Li B; Zhang Y; Yu Z; Wu F; Chen D; Wu Q
Int J Biol Macromol; 2024 Feb; 259(Pt 1):129177. PubMed ID: 38176488
[TBL] [Abstract] [Full Text] [Related]
6. Revisiting the role of endogenous stat3 in HPV-positive cervical cancer cells.
Strobel TD; Weber M; Heber N; Holzer A; Hoppe-Seyler K; Hoppe-Seyler F
J Med Virol; 2023 Nov; 95(11):e29230. PubMed ID: 38009614
[TBL] [Abstract] [Full Text] [Related]
7. Total Flavonoids in
He M; Yasin K; Yu S; Li J; Xia L
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003540
[TBL] [Abstract] [Full Text] [Related]
8.
Wen B; Luo L; Zeng Z; Luo X
J Int Med Res; 2023 Nov; 51(11):3000605231208582. PubMed ID: 37950670
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
10. DUSP1 regulates the JAK2/stat3 signaling pathway through targeting miR-21 in cervical cancer cells.
Chen H; Ren S; Wan H; Wei W; Luo Y; Cai M
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):40-44. PubMed ID: 37715430
[TBL] [Abstract] [Full Text] [Related]
11. Physical interaction between stat3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control.
Thakur K; Janjua D; Aggarwal N; Chhokar A; Yadav J; Tripathi T; Chaudhary A; Senrung A; Shrivastav A; Bharti AC
Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166817. PubMed ID: 37532113
[TBL] [Abstract] [Full Text] [Related]
12. Pentoxifylline Inhibits TNF-α/TGF-β1-Induced Epithelial-Mesenchymal Transition via Suppressing the NF-κB Pathway and
Palafox-Mariscal LA; Ortiz-Lazareno PC; Jave-Suárez LF; Aguilar-Lemarroy A; Villaseñor-García MM; Cruz-Lozano JR; González-Martínez KL; Méndez-Clemente AS; Bravo-Cuellar A; Hernández-Flores G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445768
[TBL] [Abstract] [Full Text] [Related]
13. Alkaloids from
Wan Q; Xu J; Zhu C; Liu X; Tu Y; Lei J; Yu J
J Agric Food Chem; 2023 Jul; 71(27):10349-10360. PubMed ID: 37392181
[No Abstract] [Full Text] [Related]
14. SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production.
Chen L; Shi V; Wang S; Sun L; Freeman R; Yang J; Inkman MJ; Ghosh S; Ruiz F; Jayachandran K; Huang Y; Luo J; Zhang J; Cosper P; Luke CJ; Spina CS; Grigsby PW; Schwarz JK; Markovina S
J Clin Invest; 2023 Aug; 133(15):. PubMed ID: 37279067
[TBL] [Abstract] [Full Text] [Related]
15. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract] [Full Text] [Related]
16. HOTAIR knockdown impairs metastasis of cervical cancer cells by down-regulating metastasis-related genes.
Shi L; Zhang D; Han H; Zhang L; Li S; Yang F; He C
J Obstet Gynaecol; 2023 Dec; 43(1):2181060. PubMed ID: 36972141
[TBL] [Abstract] [Full Text] [Related]
17. LRRC75A-AS1 delivered by M2 macrophage exosomes promotes cervical cancer progression via enhancing SIX1 expression.
Sui HY; Cui XY; Shi CX; Yan ZP; Li HC; Wang F
Cancer Sci; 2023 Jun; 114(6):2634-2649. PubMed ID: 36892427
[TBL] [Abstract] [Full Text] [Related]
18.
Łaska G; Sieniawska E; Maciejewska-Turska M; Świątek Ł; Pasco DS; Balachandran P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674653
[TBL] [Abstract] [Full Text] [Related]
19. Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
Chopra S; Mulani J; Mittal P; Singh M; Shinde A; Gurram L; Scaria L; Aravindakshan D; Kohle S; Rane P; Ghadi Y; Rath S; Ghosh J; Gulia S; Gupta S; Kinhikar R; Laskar S; Agarwal JP
Brachytherapy; 2023; 22(2):125-131. PubMed ID: 36585283
[TBL] [Abstract] [Full Text] [Related]
20. Resveratrol against cervical cancer: Evidence from In Vitro and In Vivo Studies.
Nadile M; Retsidou MI; Gioti K; Beloukas A; Tsiani E
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558430
[TBL] [Abstract] [Full Text] [Related]
[Next]
